The risk of COVID-19 death is much greater and age-dependent with type I IFN autoantibodies
Jérémy Manry(CEA Paris-Saclay), Luisa Imberti(Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia), D. Sène(Assistance Publique – Hôpitaux de Paris), Stéphanie Gentile(Aix-Marseille Université), Paul Bastard(Inserm), Julien Poissy(Centre National de la Recherche Scientifique), Hans-Heinrich Hoffmann(Rockefeller University), Liis Haljasmägi(University of Tartu), Sophie Trouillet‐Assant(Université Claude Bernard Lyon 1), Marina García-Prat(Universitat Autònoma de Barcelona), Quentin Philippot(Inserm), Adrian Gervais(Inserm), Junko Tanaka(Hiroshima University), James R. Heath(California Institute of Technology), Pierre Garçon, Blanca Amador-Borrero(Assistance Publique – Hôpitaux de Paris), Vasiliki Triantafyllia(Academy of Athens), Shohei Eto(Hiroshima University), Tomohiro Morio(Tokyo Institute of Psychiatry), Jesús Troya(Hospital Universitario Infanta Leonor), Alexandre Bélot(Université Claude Bernard Lyon 1), Elana Shaw, Jean‐Christophe Lagier(Méditerranée Infection Foundation), Charles‐Édouard Luyt(Inserm), Alba Parra-Martínez(Universitat Autònoma de Barcelona), Lucy Bizien(Inserm), Juan‐Manuel Anaya(University of the Coast), Jérémie Rosain(Inserm), Bruno Mégarbane(Hôpital Avicenne), Eleftherios Michailidis(Rockefeller University), Jordi Solé‐Violán(Hospital Universitario de Gran Canaria Doctor Negrín), Mélanie Migaud(Inserm), Yacine Tandjaoui-Lambiotte(Université Sorbonne Paris Nord), Tom Le Voyer(Inserm), José Luis Franco(Universidad de Antioquia), Jacques G. Rivière(Universitat Autònoma de Barcelona), Arnaud Fekkar(Inserm), Kahina Saker(Lyon 1 Université), Pascal Morel, Fabrice Cognasse(Lyon 1 Université), Pierre‐Louis Tharaux(Inserm), Julia Maslovskaja(University of Tartu), Alain Stépanian(Hôpital Fernand-Widal), David Dalmau(University Hospital Mútua de Terrassa), Pascale Richard(Établissement Français du Sang), Rui Yang(Chinese Academy of Medical Sciences & Peking Union Medical College), Lindsey B. Rosen(National Institutes of Health), Alexandre Gaudet, Nicolas de Prost(Inserm), Karita Särekannu(Institute of Clinical Research)
Cited by 24
Related Papers
Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients
|Science|2020|3.2k
Electronically Configurable Molecular-Based Logic Gates
|Science|1999|1.5k
A [2]Catenane-Based Solid State Electronically Reconfigurable Switch
|Science|2000|1.4k